Page last updated: 2024-08-24

ranolazine and Cancer of Prostate

ranolazine has been researched along with Cancer of Prostate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Yildirim-Kahriman, S1
Agarwal, R; Bergman, BC; Guth, A; Jordan, K; Minic, A; Monk, E; Schlaepfer, IR; Zemski-Berry, KA1
Altun, S; Bugan, I; Djamgoz, MBA; Dodson, A; Foster, CS; Fraser, SP; Karagoz, Z; Kaya, H; Kucuk, S1
D'Amico, AV; Goldhaber, SZ1

Reviews

1 review(s) available for ranolazine and Cancer of Prostate

ArticleYear
Effect of Voltage-Gated Sodium Channel Inhibitors on the Metastatic Behavior of Prostate Cancer Cells: A Meta-Analysis.
    Pakistan journal of biological sciences : PJBS, 2023, Volume: 26, Issue:8

    Topics: Humans; Male; Prostatic Neoplasms; Ranolazine; Sodium Channels; Tetrodotoxin; Voltage-Gated Sodium Channel Blockers

2023

Other Studies

3 other study(ies) available for ranolazine and Cancer of Prostate

ArticleYear
Targeting Fat Oxidation in Mouse Prostate Cancer Decreases Tumor Growth and Stimulates Anti-Cancer Immunity.
    International journal of molecular sciences, 2020, Dec-18, Volume: 21, Issue:24

    Topics: Adipose Tissue; Animals; Biomarkers, Tumor; CD8-Positive T-Lymphocytes; Cytotoxicity, Immunologic; Dendritic Cells; Immunity; Lipid Metabolism; Male; Mice; Molecular Targeted Therapy; Oxidation-Reduction; Prostatic Neoplasms; Ranolazine; Tumor Burden

2020
Anti-metastatic effect of ranolazine in an in vivo rat model of prostate cancer, and expression of voltage-gated sodium channel protein in human prostate.
    Prostate cancer and prostatic diseases, 2019, Volume: 22, Issue:4

    Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; NAV1.7 Voltage-Gated Sodium Channel; Prostate; Prostatic Neoplasms; Ranolazine; Rats; Tissue Array Analysis; Voltage-Gated Sodium Channel Blockers

2019
Ask the doctor. A year ago, I had an orchiectomy for prostate cancer; my PSA is now 0.74. Not long afterward, I had two cardiac stents implanted. I still have some angina and shortness of breath. I started Ranexa a couple of weeks ago, which helps my angi
    Harvard heart letter : from Harvard Medical School, 2010, Volume: 20, Issue:11

    Topics: Acetanilides; Angina Pectoris; Cardiovascular Agents; Health Knowledge, Attitudes, Practice; Humans; Male; Orchiectomy; Piperazines; Prostate-Specific Antigen; Prostatic Neoplasms; Ranolazine; Testosterone

2010